Merck & Co. (MRK) stock forecast for 2023

The forecast has been updated: February 7, 2023 6:26


Merck & Co. stock price online today

Analyst Target Price

117.52

Dividend Date

10.04.2023

Ex Dividend Date

14.03.2023

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Merck & Co. stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Merck & Co. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $117.52 target price for Merck & Co. stock stock.

Today 200 Day Moving Average is the support level (95.68 $).

50 Day Moving Average is the resistance level (109.58 $).




MRK Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Mar 102.45 100.44 105.73 5.00 %
Apr 102.00 101.10 103.92 2.71 %
May 103.18 100.66 106.11 5.13 %
Jun 102.81 100.96 104.78 3.65 %
Jul 99.40 98.24 101.70 3.40 %
Aug 99.60 97.48 102.07 4.49 %
Sep 100.19 97.71 102.88 5.03 %
Oct 98.19 97.17 101.33 4.11 %
Nov 96.85 94.88 98.40 3.58 %
Dec 94.30 91.51 95.77 4.45 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Merck & Co. stock.


Merck & Co. overview

Merck & Co. Address

2000 GALLOPING HILL ROAD, KENILWORTH, NJ, US

Market Capitalization

260 994 073 000 $

EBITDA

24 074 000 000

PE Ratio

17.07

PEG Ratio

1.359

Dividend Per Share

2.72

Dividend Yield

0.0273

EPS

6.03

Quarterly Earnings Growth YOY

-0.289

Quarterly Revenue Growth YOY

0.137

Trailing PE

17.07

Forward PE

14.75

EV To Revenue

5.12

EV To EBITDA

13.96

52 Week High

115.49

52 Week Low

70.61

50 Day Moving Average

109.58

200 Day Moving Average

95.68

Shares Outstanding

2535400000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Merck & Co. stock forecast for this year


Merck & Co. stock forecast for Mar 2023.
Estimated Average Forecasted Merck & Co. Price: 102.45. Positive monthly dynamics of the instrument is expected with 5.000% volatility is expected.

Pessimistic forecast: 100.44

Optimistic: 105.73


Merck & Co. stock forecast for Apr 2023.
Estimated Average Forecasted Merck & Co. Price: 102.00. Negative monthly dynamics of the instrument is expected with 2.710% volatility is expected.

Pessimistic forecast: 101.10

Optimistic: 103.92


Merck & Co. stock forecast for May 2023.
Estimated Average Forecasted Merck & Co. Price: 103.18. Positive monthly dynamics of the instrument is expected with 5.133% volatility is expected.

Pessimistic forecast: 100.66

Optimistic: 106.11


Merck & Co. stock forecast for Jun 2023.
Estimated Average Forecasted Merck & Co. Price: 102.81. Negative monthly dynamics of the instrument is expected with 3.650% volatility is expected.

Pessimistic forecast: 100.96

Optimistic: 104.78


Merck & Co. stock forecast for Jul 2023.
Estimated Average Forecasted Merck & Co. Price: 99.40. Negative monthly dynamics of the instrument is expected with 3.401% volatility is expected.

Pessimistic forecast: 98.24

Optimistic: 101.70


Merck & Co. stock forecast for Aug 2023.
Estimated Average Forecasted Merck & Co. Price: 99.60. Positive monthly dynamics of the instrument is expected with 4.489% volatility is expected.

Pessimistic forecast: 97.48

Optimistic: 102.07


Merck & Co. stock forecast for Sep 2023.
Estimated Average Forecasted Merck & Co. Price: 100.19. Positive monthly dynamics of the instrument is expected with 5.025% volatility is expected.

Pessimistic forecast: 97.71

Optimistic: 102.88


Merck & Co. stock forecast for Oct 2023.
Estimated Average Forecasted Merck & Co. Price: 98.19. Negative monthly dynamics of the instrument is expected with 4.109% volatility is expected.

Pessimistic forecast: 97.17

Optimistic: 101.33


Merck & Co. stock forecast for Nov 2023.
Estimated Average Forecasted Merck & Co. Price: 96.85. Negative monthly dynamics of the instrument is expected with 3.583% volatility is expected.

Pessimistic forecast: 94.88

Optimistic: 98.40


Merck & Co. stock forecast for Dec 2023.
Estimated Average Forecasted Merck & Co. Price: 94.30. Negative monthly dynamics of the instrument is expected with 4.451% volatility is expected.

Pessimistic forecast: 91.51

Optimistic: 95.77



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.07 (04.11.2022) 1.68 %
AbbVie Inc.
ABBV 145.2 (03.02.2023) 0.25 %
Aeterna Zentaris Inc.
AEZS 4.01 (04.11.2022) 2.82 %
Allakos Inc.
ALLK 5.99 (04.11.2022) 5.83 %
Allogene Therapeutics, Inc.
ALLO 9.34 (04.11.2022) -1.89 %
Amgen Inc.
AMGN 269.04 (04.11.2022) 1.19 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.75 (04.11.2022) 2.15 %
Aurora Cannabis Inc.
ACB 1.31 (04.11.2022) -5.07 %
Becton Dickinson and Company
BDX 220.84 (04.11.2022) -0.07 %
Biogen Inc.
BIIB 281.82 (04.11.2022) 0.56 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 15.47 (04.11.2022) 4.60 %
BioNTech SE
BNTX 142.06 (03.02.2023) -1.62 %
bluebird bio, Inc.
BLUE 6.13 (04.11.2022) -2.23 %
Boston Scientific Corp.
BSX 41.59 (04.11.2022) 0.14 %
Bristol-Myers Squibb Company
BMY 78.78 (04.11.2022) 0.38 %
Canopy Growth Corp.
CGC 3.29 (04.11.2022) -4.64 %
Castle Biosciences, Inc.
CSTL 21.94 (04.11.2022) -9.60 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 19.96 (04.11.2022) 2.20 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 8.32 (04.11.2022) 4.92 %
Gilead Sciences, Inc.
GILD 80.34 (04.11.2022) 1.11 %
GlaxoSmithKline plc
GSK 32.99 (04.11.2022) 0.46 %
GoodRx Holdings, Inc.
GDRX 5.06 (04.11.2022) 3.27 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.3 (04.11.2022) 0.52 %
Inovio Pharmaceuticals, Inc.
INO 2.11 (04.11.2022) -1.40 %
Johnson & Johnson
JNJ 163.36 (06.02.2023) -0.76 %
Medtronic plc.
MDT 84.65 (04.11.2022) 0.75 %
Merck & Co., Inc.
MRK 104.03 (06.02.2023) 1.06 %
Moderna, Inc.
MRNA 173.25 (03.02.2023) -1.76 %
Novartis AG
NVS 81.72 (04.11.2022) 1.67 %
Novavax, Inc.
NVAX 19.4 (04.11.2022) -3.82 %
ObsEva SA
OBSV 0.1688 (04.11.2022) 0.60 %
OrganiGram Holdings Inc.
OGI 0.9738 (04.11.2022) 0.11 %
Pfizer Inc.
PFE 44.06 (03.02.2023) -0.63 %
Regeneron Pharmaceuticals, Inc.
REGN 740.21 (04.11.2022) 0.21 %
Sanofi
SNY 43.62 (04.11.2022) 1.82 %
Schrodinger, Inc.
SDGR 20.92 (04.11.2022) -15.17 %
Senseonics Holdings, Inc.
SENS 1.18 (04.11.2022) -0.84 %
Sorrento Therapeutics, Inc.
SRNE 1.46 (04.11.2022) -1.35 %
Stryker Corp.
SYK 210.98 (04.11.2022) 2.66 %
Sundial Growers Inc.
SNDL 2.32 (04.11.2022) -2.52 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.47 (04.11.2022) -1.63 %
Thermo Fisher Scientific Inc.
TMO 495.55 (04.11.2022) 1.77 %
Tilray, Inc.
TLRY 3.81 (04.11.2022) -0.26 %
UnitedHealth Group, Inc.
UNH 472.02 (03.02.2023) 0.25 %
Veeva Systems Inc.
VEEV 166.81 (04.11.2022) -0.20 %
Zomedica Corp.
ZOM 0.2245 (04.11.2022) -2.01 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.6302 (03.02.2023) 3.21 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.